Glogenix Pharma Private Limited
About Glogenix Pharma Private Limited
Data last updated:
Glogenix Pharma Private Limited is a private limited company based in Tirupati, Andhra Pradesh, India. It operates in the dental care and orthodontics segment of the healthcare sector. It was incorporated on 06 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U36999AP2019PTC112073. Its GSTIN is 37AAHCD2811N1ZH (Andhra Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Kanchana Nappa (Managing Director) and Prakash Sajja.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 18 – 1 – 514 Bhavani Nagar, Tirupati, Andhra Pradesh, India – 517501.
As per the financials filed for FY 2023, the company reported a revenue of ₹19.64 Lakh, a growth of 43% compared to the previous year. For the same year it recorded a net loss of ₹18,000 (net margin -0.9%) and EBITDA of ₹2.17 Lakh (EBITDA margin 11.1%). Revenue has grown at a compounded annual rate (CAGR) of 95% over three years.
Company details
Contact details
Glogenix Pharma Private Limited's registered office is in Tirupati, Andhra Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address18 – 1 – 514 Bhavani Nagar, Tirupati, Andhra Pradesh, India – 517501
- IndustryHealthcare, Dental Care & Orthodontics
To see the full contact details of Glogenix Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Glogenix Pharma Private Limited
FY 2025 filings availableGlogenix Pharma Private Limited reported revenue of ₹19.64 Lakh (up 43% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 95% over three years, including 43% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹19.64 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.17 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹18,000 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 11.1% | |||
| Net Profit Margin | -0.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Glogenix Pharma Private Limited, buy the company report.
Board of directors of Glogenix Pharma Private Limited
Glogenix Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prakash Sajja | Director | 06 Jun 2019 | 7 Years 4 Months | Current |
| Kanchana Nappa | Managing Director | 06 Jun 2019 | 7 Years 4 Months | Current |
| Venkateshwarulu Napa Gunasekar | Director | 06 Jun 2019 | 7 Years 4 Months | Current |
Auditor
Glogenix Pharma Private Limited is audited by S.VARADARAJAN AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.VARADARAJAN AND CO | FY 2023 | 008579S |
Shareholding
The shareholding of Glogenix Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Glogenix Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Glogenix Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glogenix Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Glogenix Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAHCD2811N1ZH | Andhra Pradesh | Active | 22 Jun 2019 |
To see the full GST registrations and return filing status of Glogenix Pharma Private Limited, buy the company report.
Recent activity
Glogenix Pharma Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Kanchana Nappa was appointed as Managing Director on 06 Jun 2019.
Frequently asked questions
Glogenix Pharma is an active private limited company based in Tirupati, Andhra Pradesh, India. The company works in dental care and orthodontics, within the healthcare industry. It was incorporated on 06 June 2019 (7+ years old) and is registered under CIN U36999AP2019PTC112073.
Glogenix Pharma has 3 current directors:
- Kanchana Nappa - Managing Director
- Prakash Sajja - Director
- Venkateshwarulu Napa Gunasekar - Director
The latest financial statements of Glogenix Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Glogenix Pharma is 37AAHCD2811N1ZH, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Glogenix Pharma is U36999AP2019PTC112073. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glogenix Pharma was incorporated on 06 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Vijayawada.
Kanchana Nappa was appointed as Managing Director on 06 Jun 2019. Prakash Sajja was appointed as Director on 06 Jun 2019. Venkateshwarulu Napa Gunasekar was appointed as Director on 06 Jun 2019.
The registered office of Glogenix Pharma is at 18 – 1 – 514 Bhavani Nagar, Tirupati, Andhra Pradesh, India – 517501.
Glogenix Pharma operates in the healthcare industry, in the dental care and orthodontics segment.
Glogenix Pharma can be reached at its registered office: 18 – 1 – 514 Bhavani Nagar, Tirupati, Andhra Pradesh, India – 517501.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
